Hauschild A - Search Results

1

[Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].

Hauschild A, Dummer R, Garbe C, Kaufmann R, Schadendorf D, Soyer HP, Stadler R, Tilgen W. Hauschild A, et al. Hautarzt. 1998 Mar;49(3):167-9. doi: 10.1007/s001050050722. Hautarzt. 1998. PMID: 9565782 German. No abstract available.

2

[Systemic treatment of melanoma. Current clinical trials].

Hauschild A, Rass K, Tilgen W. Hauschild A, et al. Hautarzt. 2008 Jun;59(6):484-91. doi: 10.1007/s00105-008-1569-0. Hautarzt. 2008. PMID: 18478195 Review. German.

3

[Protocol for optimal therapy of malignant melanoma in the metastatic stage by the Dermatologic Oncology Working Group].

Hauschild A. Hauschild A. Hautarzt. 1996 Jan;47(1):67-8. doi: 10.1007/s001050050380. Hautarzt. 1996. PMID: 8835010 Clinical Trial. German. No abstract available.

4

[Cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].

Hauschild A, Garbe C. Hauschild A, et al. Hautarzt. 1998 Oct;48 Suppl 1:S27-9. Hautarzt. 1998. PMID: 9866045 German. No abstract available.

5

[Current comments on the dermatological oncology working groups' work on high dose therapy with interferon alpha 2b].

Hauschild A. Hauschild A. Hautarzt. 1999 Jun;50(6):395-7. doi: 10.1007/s001050050930. Hautarzt. 1999. PMID: 10427506 German. No abstract available.

6

[Adjuvant drug therapy of malignant melanoma. Current knowledge and multi-center studies in German-speaking countries].

Hauschild A, Volkenandt M, Garbe C. Hauschild A, et al. Dtsch Med Wochenschr. 2000 Oct 20;125(42):1272-8. doi: 10.1055/s-2000-7854. Dtsch Med Wochenschr. 2000. PMID: 11098240 Review. German. No abstract available.

7

Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).

Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W. Hauschild A, et al. Br J Cancer. 2001 Apr 20;84(8):1036-42. doi: 10.1054/bjoc.2001.1731. Br J Cancer. 2001. PMID: 11308250 Free PMC article. Clinical Trial.

8

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).

Spieth K, Kaufmann R, Dummer R, Garbe C, Becker JC, Hauschild A, Tilgen W, Ugurel S, Beyeler M, Bröcker EB, Kaehler KC, Pföhler C, Gille J, Leiter U, Schadendorf D. Spieth K, et al. Among authors: hauschild a. Ann Oncol. 2008 Apr;19(4):801-6. doi: 10.1093/annonc/mdm565. Epub 2008 Jan 4. Ann Oncol. 2008. PMID: 18178958 Free article. Clinical Trial.

9

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Dummer R, Hauschild A, Jost L; ESMO Guidelines Working Group. Dummer R, et al. Among authors: hauschild a. Ann Oncol. 2008 May;19 Suppl 2:ii86-8. doi: 10.1093/annonc/mdn100. Ann Oncol. 2008. PMID: 18456782 Free article. No abstract available.

10

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Dummer R, Hauschild A, Pentheroudakis G. Dummer R, et al. Among authors: hauschild a. Ann Oncol. 2009 May;20 Suppl 4:129-31. doi: 10.1093/annonc/mdp152. Ann Oncol. 2009. PMID: 19454433 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters